
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.
Profits are valuable, but they’re not everything. At StockStory, we help you identify the companies that have real staying power. Keeping that in mind, here are three profitable companies to steer clear of and a few better alternatives.
VF Corp (VFC)
Trailing 12-Month GAAP Operating Margin: 6.2%
Owner of The North Face, Vans, and Supreme, VF Corp (NYSE: VFC) is a clothing conglomerate specializing in branded lifestyle apparel, footwear, and accessories.
Why Are We Out on VFC?
- Sales were flat over the last five years, indicating it’s failed to expand its business
- Lacking free cash flow generation means it has few chances to reinvest for growth, repurchase shares, or distribute capital
- Waning returns on capital from an already weak starting point displays the inefficacy of management’s past and current investment decisions
At $16.91 per share, VF Corp trades at 15.3x forward P/E. To fully understand why you should be careful with VFC, check out our full research report (it’s free).
Sinclair (SBGI)
Trailing 12-Month GAAP Operating Margin: 5.8%
With over 2,400 hours of local news produced weekly and 640 broadcast channels reaching millions of American homes, Sinclair (NASDAQ: SBGI) operates a network of 185 local television stations across 86 U.S. markets, producing news programming and distributing content from major networks.
Why Should You Sell SBGI?
- Products and services are facing significant end-market challenges during this cycle as sales have declined by 11.4% annually over the last five years
- Eroding returns on capital suggest its historical profit centers are aging
- High net-debt-to-EBITDA ratio of 7× could force the company to raise capital on unfavorable terms if market conditions deteriorate
Sinclair’s stock price of $13.81 implies a valuation ratio of 22.2x forward P/E. Dive into our free research report to see why there are better opportunities than SBGI.
Illumina (ILMN)
Trailing 12-Month GAAP Operating Margin: 19.4%
Pioneering the ability to read the human genome at unprecedented speed and affordability, Illumina (NASDAQ: ILMN) develops and sells advanced DNA sequencing and microarray technologies that allow researchers and clinicians to analyze genetic variations and functions.
Why Are We Hesitant About ILMN?
- Products and services are facing end-market challenges during this cycle, as seen in its flat sales over the last two years
- Core business is underperforming as its organic revenue has disappointed over the past two years, suggesting it might need acquisitions to stimulate growth
- ROIC of 0.7% reflects management’s challenges in identifying attractive investment opportunities
Illumina is trading at $191.56 per share, or 34.3x forward P/E. If you’re considering ILMN for your portfolio, see our FREE research report to learn more.
High-Quality Stocks for All Market Conditions
WHILE YOU’RE HERE: Top 9 Market-Beating Stocks. The best stocks don’t just beat the market once. They do it again. And again. Robust revenue growth, rising free cash flow, returns on capital that leave their competition in the dust. The market has already rewarded these businesses.
But our AI platform says the party isn’t over. Find out which 9 stocks made the cut this week — FREE. Get Our Top 9 Market-Beating Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+214% between June 2020 and June 2025). Find your next big winner with StockStory today.